What do researchers think about BAM15 as a safer mitochondrial uncoupler?
I’ve been noticing increasing discussion around mitochondrial uncouplers in metabolic research, especially as the GLP-1 space becomes crowded.
One compound that keeps appearing in papers and lab discussions is BAM15.
From what I understand, researchers are interested in it because it appears to increase energy expenditure without the dangerous hyperthermia issues seen in older uncouplers like DNP.
Preclinical work suggests it may have applications in:
• obesity models
• insulin resistance
• fatty liver research
• mitochondrial bioenergetics
It feels like research is slowly expanding beyond peptide-only approaches and exploring small-molecule metabolic regulators again.
Curious what people here think:
Do you see mitochondrial uncoupling becoming a serious complementary path to GLP-1 therapies in the next few years?
Would love to hear thoughts from anyone working in metabolic or mitochondrial research.